Mustang Bio Inc (MBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,098 | 75,656 | 91,364 | 107,369 | 122,216 |
| Receivables | N/A | 299 | 33 | 33 | 32 |
| TOTAL | $61,131 | $78,852 | $94,447 | $109,376 | $124,153 |
| Non-Current Assets | |||||
| PPE Net | 8,657 | 9,391 | 10,045 | 10,200 | 10,511 |
| Other Non-Current Assets | 3,819 | 4,179 | 4,344 | 2,329 | 2,297 |
| TOTAL | $12,476 | $13,570 | $14,389 | $12,529 | $12,808 |
| Total Assets | $73,607 | $92,422 | $108,836 | $121,905 | $136,961 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,438 | 13,731 | 12,810 | 10,165 | 9,615 |
| Accrued Expenses | 601 | 766 | 152 | 448 | 811 |
| TOTAL | $12,668 | $15,109 | $13,557 | $10,981 | $10,784 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,579 | 27,436 | 27,293 | 27,150 | 26,986 |
| Other Non-Current Liabilities | 3,275 | 3,334 | 3,391 | 1,496 | 1,590 |
| TOTAL | $31,124 | $31,040 | $30,954 | $28,916 | $28,846 |
| Total Liabilities | $43,792 | $46,149 | $44,511 | $39,897 | $39,630 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 163 | 147 | 143 | 141 | 137 |
| Common Shares | 1 | 1,120 | 15 | 38 | 37 |
| Retained earnings | -346,062 | -329,369 | -309,735 | -290,738 | -271,639 |
| TOTAL | $29,815 | $46,273 | $64,325 | $82,008 | $97,331 |
| Total Liabilities And Equity | $73,607 | $92,422 | $108,836 | $121,905 | $136,961 |